Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran 
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound 
Thailand Inflation Remains Negative for 10th Straight Month in January 
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices 
Moderna appointed Jorge Gomez as its new chief financial officer in April, and it was revealed that he also left his position just two days into the role. The American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, announced this week that its CFO is leaving immediately.
It is not clear if Gomez was fired or if he resigned from his post as the newly-appointed CFO at Moderna. But it was reported that his departure is related to Dentsply Sirona Inc.’s ongoing internal financial probe. The said company was Gomez’s former employer, and it recently disclosed the investigation.
“The Audit Committee is also investigating allegations that certain former and current members of senior management directed the company’s use of these incentives and other actions to achieve executive compensation targets in 2021,” New York Post quoted Dentsply as stating in a filing.
According to Fox Business, the probe is focused on the dental equipment and supplies manufacturing company’s utilization of incentives to sell its dental products to distributors. The investigation covers the sales for the third and fourth quarters of 2021.
Investigators are checking if those incentives were properly accounted for and if those sales were disclosed in periodic reports to the U.S. Securities and Exchange Commission (SEC). Since Gomez has worked in Dentsply Sirona’s financial unit, so there is a possibility that he could also be investigated; thus, he left Moderna not long after being named as its CFO.
“Today announced that its recently appointed Chief Financial Officer, Jorge Gomez, has departed the Company, effective immediately,” Moderna stated in a press release. “The announcement follows the May 10 public disclosure by Mr. Gomez's former employer, Dentsply Sirona Inc., of an ongoing internal investigation into certain matters, including financial reporting.”
Moderna also announced that Davide Meline would continue his work as the company’s CFO following Gomez’s exit. It was reported that Gomez will still get his 12 months' salary which is said to be $700,000 in total, and Consolidated Omnibus Budget Reconciliation Act (COBRA) coverage for one year. Then again, he will be forfeiting his signing bonus and eligibility for relocation reimbursements.
